VectivBio secures investments totaling 110 million dollars The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars…martin10.19.2020
Monte Rosa Therapeutics banks 96 million US dollars The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US…martin09.28.2020
Roche launches new coronavirus antibody test Roche is launching on the market a new antibody test to determine coronavirus infections. This…martin09.18.2020
Investors see great potential in Polyneuron The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised…martin09.17.2020
Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of…martin09.15.2020
Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization…martin09.04.2020
Hengrui Medicine sets up clinical research and development in Basel The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The…martin09.02.2020
Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in…martin08.31.2020
New label guarantees that data remains in Switzerland With the new “swiss hosting” label, the Basel-based company swiss made software Gmbh is guaranteeing…martin08.28.2020
Moderna driving forward production of vaccine from Basel Moderna is opening a location in Basel and is advancing the production of the coronavirus…martin08.11.2020